Blog
Contributors
Products
Subscribe
Contact Us
  • Search the Blog
  • Search for Topics
  • Search for Keywords
  • Search for Authors
1 min read

U.S. Navy to Deploy Floating Hospitals with Beckman Coulter Equipment on Board

BY Editorial Team |May 1 2020
Our hematology and microbiology systems will be on board U.S. naval ships providing general hospital relief during the COVID-19 outbreak.
U.S. Navy to Deploy Floating Hospitals with Beckman Coulter Equipment on Board

On March 18, President Trump announced that the U.S. Navy will deploy the USNS Comfort and Mercy Naval Floating Hospitals to New York and Los Angeles, respectively. These naval ships will provide general hospital relief, allowing local hospitals to focus their attention on COVID-19 cases. We’re proud to have hematology and microbiology systems on board to alleviate medical needs in those locations.

For more than 16 years, we have supplied the U.S. Navy with the medical equipment needed to support humanitarian relief operations both domestically and globally.

You can read more on the U.S. Department of Defense website.

News COVID-19
Editorial Team
Editorial Team
The Beckman Coulter editorial team brings you timely news and resources focused on elevating clinical laboratory performance and advancing patient care.
See all by Editorial Team

Related Articles

It’s Time to Be Seen: Re-architecting Healthcare for Women—And Why Everyone Gains

It’s Time to Be Seen: Re-architecting Healthcare for Women—And Why Everyone Gains

BY Editorial Team |March 20 2026
5 min read
Women's health is often narrowly defined by reproductive care, overlooking critical issues like cardiovascular disease, infective endocarditis, heart failure, and mental health.
Read More
Advancing Clinical Capabilities to Empower Better Outcomes

Advancing Clinical Capabilities to Empower Better Outcomes

BY Editorial Team |February 4 2026
5 min read
Discover how our philosophy of Advancing Clinical Capabilities is helping us deliver greater insights in areas like women’s health, cardiovascular disease, infectious disease, and beyond.
Read More
Rethinking Heart Failure Diagnosis in an Era of Rising Obesity

Rethinking Heart Failure Diagnosis in an Era of Rising Obesity

BY Julian Braz |January 26 2026
5 min read
As obesity rates climb toward 50% of the U.S. population, clinicians face a growing diagnostic challenge: obesity is associated with lower NT-proBNP levels, potentially masking heart failure in the patients most at risk.
Read More
Products
Support
Company Newsletter
Beckman Coulter Life Sciences
Stay Connected
Products
Support
Company
Newsletter
Beckman Coulter Life Sciences
Stay Connected


Information addressed to health professionals. The products presented on this site are for professional use only, and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

 

© 2026 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. 

All trademarks used herein are the property of their respective owners.

U.S. Government Users Restricted Rights - As per GSA ADP Schedule Contract with Beckman Coulter, Inc., the use, duplication or disclosure is restricted as follows: Beckman Coulter hereby authorizes user to copy those documents published on the World Wide Web by Beckman Coulter, for noncommercial use, and only within the user's organization. Except as expressly provided above, nothing contained herein shall be construed as granting any license or right under any Beckman Coulter copyright. Nothing contained herein shall be construed as granting by implication, estoppel or otherwise any license or right under any patent or trademark of Beckman Coulter or any third party.